NEWTEKONE INC (NEWT) Fundamental Analysis & Valuation

NASDAQ:NEWT • US6525262035

Current stock price

10.46 USD
-0.61 (-5.51%)
At close:
10.48 USD
+0.02 (+0.19%)
After Hours:

This NEWT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. NEWT Profitability Analysis

1.1 Basic Checks

  • NEWT had positive earnings in the past year.
  • NEWT had a negative operating cash flow in the past year.
  • NEWT had positive earnings in each of the past 5 years.
  • In the past 5 years NEWT reported 4 times negative operating cash flow.
NEWT Yearly Net Income VS EBIT VS OCF VS FCFNEWT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M

1.2 Ratios

  • The Return On Assets of NEWT (2.12%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 14.63%, NEWT is in the better half of the industry, outperforming 79.00% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 4.06%, NEWT is doing good in the industry, outperforming 62.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for NEWT is below the industry average of 8.07%.
  • The last Return On Invested Capital (4.06%) for NEWT is above the 3 year average (3.79%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.12%
ROE 14.63%
ROIC 4.06%
ROA(3y)2.57%
ROA(5y)3.78%
ROE(3y)16.56%
ROE(5y)15.82%
ROIC(3y)3.79%
ROIC(5y)5.19%
NEWT Yearly ROA, ROE, ROICNEWT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • NEWT has a better Profit Margin (18.80%) than 78.00% of its industry peers.
  • NEWT's Profit Margin has declined in the last couple of years.
  • The Operating Margin of NEWT (46.39%) is better than 85.00% of its industry peers.
  • NEWT's Operating Margin has declined in the last couple of years.
  • NEWT has a better Gross Margin (94.25%) than 98.00% of its industry peers.
Industry RankSector Rank
OM 46.39%
PM (TTM) 18.8%
GM 94.25%
OM growth 3Y-4.87%
OM growth 5Y-4.75%
PM growth 3Y-5.91%
PM growth 5Y-10.33%
GM growth 3YN/A
GM growth 5YN/A
NEWT Yearly Profit, Operating, Gross MarginsNEWT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. NEWT Health Analysis

2.1 Basic Checks

  • NEWT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • NEWT has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for NEWT has been increased compared to 5 years ago.
  • NEWT has about the same debt/assets ratio as last year.
NEWT Yearly Shares OutstandingNEWT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
NEWT Yearly Total Debt VS Total AssetsNEWT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of -0.12, we must say that NEWT is in the distress zone and has some risk of bankruptcy.
  • NEWT has a worse Altman-Z score (-0.12) than 62.00% of its industry peers.
  • NEWT has a Debt/Equity ratio of 5.63. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 5.63, NEWT is not doing good in the industry: 78.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 5.63
Debt/FCF N/A
Altman-Z -0.12
ROIC/WACC0.74
WACC5.46%
NEWT Yearly LT Debt VS Equity VS FCFNEWT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M

2.3 Liquidity

  • A Current Ratio of 0.19 indicates that NEWT may have some problems paying its short term obligations.
  • NEWT's Current ratio of 0.19 is on the low side compared to the rest of the industry. NEWT is outperformed by 68.00% of its industry peers.
  • NEWT has a Quick Ratio of 0.19. This is a bad value and indicates that NEWT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of NEWT (0.19) is worse than 68.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
NEWT Yearly Current Assets VS Current LiabilitesNEWT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. NEWT Growth Analysis

3.1 Past

  • The earnings per share for NEWT have decreased strongly by -50.26% in the last year.
  • The earnings per share for NEWT have been decreasing by -13.98% on average. This is quite bad
  • The Revenue has grown by 13.34% in the past year. This is quite good.
  • NEWT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.47% yearly.
EPS 1Y (TTM)-50.26%
EPS 3Y-23.3%
EPS 5Y-13.98%
EPS Q2Q%-5.8%
Revenue 1Y (TTM)13.34%
Revenue growth 3Y29.32%
Revenue growth 5Y24.47%
Sales Q2Q%-4.6%

3.2 Future

  • NEWT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.82% yearly.
  • NEWT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.39% yearly.
EPS Next Y144.13%
EPS Next 2Y61.36%
EPS Next 3Y46.82%
EPS Next 5YN/A
Revenue Next Year14.33%
Revenue Next 2Y13.39%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NEWT Yearly Revenue VS EstimatesNEWT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
NEWT Yearly EPS VS EstimatesNEWT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

7

4. NEWT Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.78 indicates a reasonable valuation of NEWT.
  • Compared to the rest of the industry, the Price/Earnings ratio of NEWT is on the same level as its industry peers.
  • When comparing the Price/Earnings ratio of NEWT to the average of the S&P500 Index (24.88), we can say NEWT is valued rather cheaply.
  • A Price/Forward Earnings ratio of 4.42 indicates a rather cheap valuation of NEWT.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of NEWT indicates a rather cheap valuation: NEWT is cheaper than 88.00% of the companies listed in the same industry.
  • NEWT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 10.78
Fwd PE 4.42
NEWT Price Earnings VS Forward Price EarningsNEWT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NEWT is valued cheaply inside the industry as 87.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.08
NEWT Per share dataNEWT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

  • NEWT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as NEWT's earnings are expected to grow with 46.82% in the coming years.
PEG (NY)0.07
PEG (5Y)N/A
EPS Next 2Y61.36%
EPS Next 3Y46.82%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. NEWT Dividend Analysis

5.1 Amount

  • NEWT has a Yearly Dividend Yield of 6.60%, which is a nice return.
  • NEWT's Dividend Yield is rather good when compared to the industry average which is at 2.50. NEWT pays more dividend than 86.00% of the companies in the same industry.
  • NEWT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.90.
Industry RankSector Rank
Dividend Yield 6.6%

5.2 History

  • The dividend of NEWT decreases each year by -12.63%.
  • NEWT has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of NEWT decreased recently.
Dividend Growth(5Y)-12.63%
Div Incr Years1
Div Non Decr Years1
NEWT Yearly Dividends per shareNEWT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • NEWT pays out 48.20% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP48.2%
EPS Next 2Y61.36%
EPS Next 3Y46.82%
NEWT Yearly Income VS Free CF VS DividendNEWT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M
NEWT Dividend Payout.NEWT Dividend Payout, showing the Payout Ratio.NEWT Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NEWT Fundamentals: All Metrics, Ratios and Statistics

NEWTEKONE INC

NASDAQ:NEWT (3/27/2026, 8:00:01 PM)

After market: 10.48 +0.02 (+0.19%)

10.46

-0.61 (-5.51%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)01-29
Earnings (Next)05-04
Inst Owners44.05%
Inst Owner Change1.1%
Ins Owners6.08%
Ins Owner Change1.84%
Market Cap322.48M
Revenue(TTM)309.46M
Net Income(TTM)58.18M
Analysts73.85
Price Target17.34 (65.77%)
Short Float %10.48%
Short Ratio9.99
Dividend
Industry RankSector Rank
Dividend Yield 6.6%
Yearly Dividend1.02
Dividend Growth(5Y)-12.63%
DP48.2%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.13%
Min EPS beat(2)-6.52%
Max EPS beat(2)2.25%
EPS beat(4)1
Avg EPS beat(4)-59.57%
Min EPS beat(4)-230.76%
Max EPS beat(4)2.25%
EPS beat(8)5
Avg EPS beat(8)-22.65%
EPS beat(12)7
Avg EPS beat(12)-14.64%
EPS beat(16)9
Avg EPS beat(16)-15.55%
Revenue beat(2)0
Avg Revenue beat(2)-8.96%
Min Revenue beat(2)-10.14%
Max Revenue beat(2)-7.77%
Revenue beat(4)1
Avg Revenue beat(4)-2.02%
Min Revenue beat(4)-10.14%
Max Revenue beat(4)16.67%
Revenue beat(8)5
Avg Revenue beat(8)2.8%
Revenue beat(12)6
Avg Revenue beat(12)2.19%
Revenue beat(16)10
Avg Revenue beat(16)20.78%
PT rev (1m)1.19%
PT rev (3m)12.58%
EPS NQ rev (1m)-0.83%
EPS NQ rev (3m)3.14%
EPS NY rev (1m)-0.36%
EPS NY rev (3m)5.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.61%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)2.3%
Valuation
Industry RankSector Rank
PE 10.78
Fwd PE 4.42
P/S 1.04
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB 0.84
EV/EBITDA 6.08
EPS(TTM)0.97
EY9.27%
EPS(NY)2.37
Fwd EY22.64%
FCF(TTM)-19.12
FCFYN/A
OCF(TTM)-18.79
OCFYN/A
SpS10.04
BVpS12.9
TBVpS12.42
PEG (NY)0.07
PEG (5Y)N/A
Graham Number16.78
Profitability
Industry RankSector Rank
ROA 2.12%
ROE 14.63%
ROCE 11.69%
ROIC 4.06%
ROICexc 4.55%
ROICexgc 5.05%
OM 46.39%
PM (TTM) 18.8%
GM 94.25%
FCFM N/A
ROA(3y)2.57%
ROA(5y)3.78%
ROE(3y)16.56%
ROE(5y)15.82%
ROIC(3y)3.79%
ROIC(5y)5.19%
ROICexc(3y)4.39%
ROICexc(5y)5.63%
ROICexgc(3y)4.84%
ROICexgc(5y)7.65%
ROCE(3y)9.67%
ROCE(5y)9.69%
ROICexgc growth 3Y-22.07%
ROICexgc growth 5Y-10.94%
ROICexc growth 3Y-11.48%
ROICexc growth 5Y-4.52%
OM growth 3Y-4.87%
OM growth 5Y-4.75%
PM growth 3Y-5.91%
PM growth 5Y-10.33%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 5.63
Debt/FCF N/A
Debt/EBITDA 15.52
Cap/Depr 1530.84%
Cap/Sales 3.3%
Interest Coverage 1.47
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z -0.12
F-Score3
WACC5.46%
ROIC/WACC0.74
Cap/Depr(3y)523.78%
Cap/Depr(5y)314.27%
Cap/Sales(3y)1.23%
Cap/Sales(5y)0.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.26%
EPS 3Y-23.3%
EPS 5Y-13.98%
EPS Q2Q%-5.8%
EPS Next Y144.13%
EPS Next 2Y61.36%
EPS Next 3Y46.82%
EPS Next 5YN/A
Revenue 1Y (TTM)13.34%
Revenue growth 3Y29.32%
Revenue growth 5Y24.47%
Sales Q2Q%-4.6%
Revenue Next Year14.33%
Revenue Next 2Y13.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y30.11%
EBIT growth 3Y23.02%
EBIT growth 5Y18.55%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-280.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-274.97%
OCF growth 3YN/A
OCF growth 5YN/A

NEWTEKONE INC / NEWT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NEWTEKONE INC?

ChartMill assigns a fundamental rating of 4 / 10 to NEWT.


Can you provide the valuation status for NEWTEKONE INC?

ChartMill assigns a valuation rating of 7 / 10 to NEWTEKONE INC (NEWT). This can be considered as Undervalued.


Can you provide the profitability details for NEWTEKONE INC?

NEWTEKONE INC (NEWT) has a profitability rating of 5 / 10.


What is the financial health of NEWTEKONE INC (NEWT) stock?

The financial health rating of NEWTEKONE INC (NEWT) is 0 / 10.


How sustainable is the dividend of NEWTEKONE INC (NEWT) stock?

The dividend rating of NEWTEKONE INC (NEWT) is 6 / 10 and the dividend payout ratio is 48.2%.